December 25, 2025 a 11:43 am
BIIB: Fundamental Ratio Analysis - Biogen Inc.
Biogen Inc. offers a wide range of therapies primarily targeting neurological and neurodegenerative diseases. The stock demonstrates a promising profile in terms of its current engagement in therapies for multiple sclerosis and Alzheimer's disease. With a diverse pipeline and strategic collaborations, BIIB remains a strong contender in the healthcare sector.
Fundamental Rating
Biogen's fundamental strength is reflected in an overall score of 4, showcasing solidity across most evaluation criteria.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return On Equity | 4 | |
| Return On Assets | 4 | |
| Debt To Equity | 2 | |
| Price To Earnings | 2 | |
| Price To Book | 4 |
Historical Rating
An overview of Biogen's historical scoring shows consistency over time, with some variations in specific metrics.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-12-24 | 4 | 5 | 4 | 4 | 2 | 2 | 4 |
| N/A | 0 | 5 | 4 | 4 | 2 | 2 | 4 |
Analyst Price Targets
Analyst price targets suggest a solid upside potential, though valuations vary considerably among experts.
| High | Low | Median | Consensus |
|---|---|---|---|
| $250 | $143 | $157 | $177.88 |
Analyst Sentiment
Analysts are generally positive about Biogen, with a consensus tilted towards buy recommendations.
| Rating | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 26 | |
| Hold | 20 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
Biogen Inc. presents a robust investment opportunity given its significant role in neurological treatments and extensive pipeline. The stock enjoys favorable analyst sentiment and a promising future outlook, particularly in expanding therapeutic areas. However, challenges such as market competition and regulatory hurdles remain relevant risks. Investors considering BIIB should weigh these factors carefully to capitalize on potential long-term growth. Overall, Biogen demonstrates a sound fundamental and strategic position in the healthcare industry.